Published Guidance, NICE advice and quality standards
Showing 111 to 120 of 2377
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Tirzepatide for treating type 2 diabetes | TA924 | ||
| Mirikizumab for treating moderately to severely active ulcerative colitis | TA925 | ||
| Baricitinib for treating severe alopecia areata | TA926 | ||
| Tabelecleucel for treating post-transplant lymphoproliferative disorder caused by the Epstein-Barr virus (terminated appraisal) | TA923 | ||
| Percutaneous deep venous arterialisation for chronic limb-threatening ischaemia | IPG773 | ||
| Stroke rehabilitation in adults | NG236 | ||
| Rimegepant for treating migraine | TA919 | ||
| Tofacitinib for treating active ankylosing spondylitis | TA920 | ||
| Ruxolitinib for treating polycythaemia vera | TA921 | ||
| Daridorexant for treating long-term insomnia | TA922 |